EFFIPRO 50 MG SPOT-ON SOLUTION FOR CATS
EFFIPRO 50 MG SPOT-ON SOLUTION FOR CATS
Authorised
- Fipronil
Product identification
Medicine name:
EFFIPRO 50 MG SPOT-ON SOLUTION FOR CATS
Effipro 50 mg Spot-on oplossing
Effipro 50 mg Solution pour spot-on
Effipro 50 mg Lösung zum Auftropfen
Active substance:
- Fipronil
Target species:
-
Cat
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Fipronil50.00/milligram(s)1.00Pipette
Pharmaceutical form:
-
Spot-on solution
Withdrawal period by route of administration:
-
Cutaneous use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AX15
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Box containing 2 pipettes of 0.5 mL
- Box containing 3 pipettes of 0.5 mL
- Box containing 4 pipettes of 0.5 mL
- Box containing 6 pipettes of 0.5 mL
- Box containing 8 pipettes of 0.5 mL
- Box containing 12 pipettes of 0.5 mL
- Box containing 24 pipettes of 0.5 mL
- Box containing 30 pipettes of 0.5 mL
- Box containing 60 pipettes of 0.5 mL
- Box containing 90 pipettes of 0.5 mL
- Box containing 150 pipettes of 0.5 mL
- Box containing 1 blister pack of 1 pipette of 0.5 mL
- Box containing 2 blister packs of 1 pipette of 0.5 mL
- Box containing 3 blister packs of 1 pipette of 0.5 mL
- Box containing 4 blister packs of 1 pipette of 0.5 mL
- Box containing 6 blister packs of 1 pipette of 0.5 mL
- Box containing 8 blister packs of 1 pipette of 0.5 mL
- Box containing 12 blister packs of 1 pipette of 0.5 mL
- Box containing 24 blister packs of 1 pipette of 0.5 mL
- Box containing 30 blister packs of 1 pipette of 0.5 mL
- Box containing 60 blister packs of 1 pipette of 0.5 mL
- Box containing 90 blister packs of 1 pipette of 0.5 mL
- Box containing 150 blister packs of 1 pipette of 0.5 mL
- Box containing 1 pipette of 0.5 mL
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0376/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 3/06/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?:
